Role of mitogen-activated protein kinases in influenza virus inducti on of prostaglandin E2 from arachidonic acid in bronchial epithelial cells

Clinical and Experimental Allergy

Volumn 33, Issue 9, 2003, Pages 1244-1251

  Mizumura, K ^a   Hashimoto, Shu ^a   Maruoka, S ^a   Gon, Y ^a   Kitamura, N ^a   Matsumoto, K ^a   Hayashi, S ^a   Shimizu, K ^a   Horie, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway inflammation; Bronchial epithelium; COX 2; Influenza virus; MAP kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARACHIDONIC ACID; CEP 11004; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOLIPASE A; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CATABOLISM; CONCENTRATION RESPONSE; CYTOSOL; DRUG SPECIFICITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; INFLUENZA; INFLUENZA VIRUS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; VIRUS CELL INTERACTION; VIRUS INDUCTION; WESTERN BLOTTING;

ARACHIDONIC ACID; BRONCHI; CELL LINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; IMMUNOBLOTTING; INFLUENZA, HUMAN; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; ORTHOMYXOVIRIDAE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 0042235524     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01750.x     Document Type: Article

References (59)

1. 2. J Biol Chem 1997; 272:25693-9.
2. Babu KS, Salvi SS. Aspirin and asthma. Chest 2000; 118:1470-6.
3. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996; 184:883-91.
4. Mitchell JA, Larkin S, Williams TJ. Cyclooxygenase-2 regulation and relevance in inflammation. Biochem Pharmacol 1995; 50:1535-42.
5. Smith WL, Garavito RM, Dewitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J Biol Chem 1996; 271:33157-60.
6. 2 synthesis in mouse osteoblasts cultured with interleukin-1. J Biol Chem 1997; 272:5952-8.
7. 2. J Biol Chem 1997; 272:16709-12.
8. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993; 72:269-78.
9. 2 are abrogated by the inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem J 1996; 319:17-20.
10. O'Neill GP, Ford-Hutchington AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993; 330:156-60.
11. Chen CC, Sun YT, Chen JJ, Chin KT. TNF-α-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-γ2, protein kinase C-α tyrosine kinase, NF-κB-inducing kinase, and I-κB kinase 1/2 pathway. J Immunol 2000; 165:2719-28.
12. Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ. Micro-tubule-interfering agents stimulate the transcription of cyclooxygenase-2. J Biol Chem 2000; 278:14838-45.
13. Dean JLE, Brook M, Clark AR, Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Immunol 1999; 274:264-9.
14. Eligini S, Habib A, Lebret M, Creminon C, Levy-Toledano S, Maclouf J. Induction of cyclooxygenase in human endothelial cells by SIN-1 in the absence of prostaglandin production. Br J Pharmacol 2001; 133:1163-71.
15. Wadleigh DJ, Reddy ST, Kopp E, Ghosh S, Herschman HR. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 2000; 275:6259-66.
16. Guan Z, Buckman SY, Miller BW, Springer LD, Morrison AR. Interleukin-1β-induced cyclooxygenase-2 expression requires activation of both c-Jun Nh2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 1998; 273:28670-6.
17. Ermert L, Emert M, Merkle M et al. Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge differential regulation in the various types of cells in the lung. Am J Pathol 2000; 156:1275-87.
18. 2 release in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000; 279:L201-7.
19. Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1β, tumor necrosis factor-αand transforming growth factor-β1 in human lung fibroblast. Exp Cell Res 1998; 241:222-9.
20. Laporte JD, Moore PE, Lahiri T, Schwartman IN, Panettieri Jr RA, Shore SA. p38 MAP kinase regulates IL-1β responses in cultured airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000; 279:932-41.
21. Chen CC, Sun YT, Chen JJ, Chang YJ. Tumor necrosis factor-α -induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases and hob kinase 1/2 in human alveolar epithelial cells. Mol Pharmacol 2001; 59:493-500.
22. Polito AJ, Proud D. Epithelial cells as regulator of airway inflammation. J Allergy Clin Immunol 1998; 102:714-8.
23. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol 1993; 74:2347-55.
24. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 1994; 68:3667-73.
25. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y. In vivo induction of apoptosis by influenza virus. J Gen Virol 1995; 76:2869-73.
26. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81:807-69.
27. Ichijo H. From receptor to stress-acti rated MAP kinase. Oncogene 1999; 45:6087-93.
28. Force T, Bnventre JV. Growth factors and mitogen-activated protein kinase. Hypertension 1998; 31:152-61.
29. Raingeaud J, Gupta S, Rogers JS et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:7420-6.
30. Hashimoto S, Matsumoto K, Gon Y, Nakayama T, Takeshita I, Horie T. Hyperosmolarity-induced IL-8 expression in human bronchial epithelial cells through p38 MAP kinase. Am J Respir Crit Care Med 1999; 159:634-40.
31. Gon Y, Hashimoto S, Matsumoto K, Nakayama T, Takeshita I, Horie T. Cooling and rewarming-induced IL-8 expression in human bronchial epithelial cells through p38MAP kinase-dependent pathway. Biochem Biophys Res Commun 1998; 249:156-60.
32. Rawadi G, Ramez V, Lemercier B, Roman-Roman S. Activation of mitogen-activated protein kinase pathways by Mycoplasma fermentans membrane lipoproteins in murine macrophages: involvement in cytokine synthesis. J Immunol 1998; 160:1330-9.
33. Tuyt LML, Dokter WHA, Birkenkamp K et al. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-jun are involved in NF-κB-dependent IL-6 expression in human monocytes. J Immunol 1999; 162:4893-902.
34. Kujime K, Hashimoto S, Gon Y, Shimizu K, Horie T. p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J Immunol 2000; 164:3222-8.
35. Lee JC, Laydon JT, McDonnell PC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739-46.
36. Allesi DR, Cuenda A, Cohen P, Dundley DT, Saltiel AR. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270:27489-94.
37. Kaneko M, Saito Y, Saito H et al. Neurotrophic 3,9-bis[(alkylthio) methyl]- and -Bis(alkoxymethyl)-K-252a derivatives. J Med Chem 1997; 40:1863-9.
38. Murakata C, Kaneko M, Gessner G et al. Mixed lineage kinase activity of indolocarbazole analogs. Bioorg Med Chem Lett 2002; 12:147-50.
39. 2 receptor gene transcription. Arch Pharmacol 2000; 361:247-54.
40. Matsumoto K, Hashimoto S, Gon Y, Nakayama T, Horie T. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase. J Allergy Clin Immunol 1998; 101:825-31.
41. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 1995; 92:12230-4.
42. Duolikun M, Hashimoto S, Gon Y et al. Interleukin-8 and RANTES production by human bronchial epithelial cells are differentially regulated by distinct MAP kinases. Nihon Univ J Med 2002; 44:61-70.
43. Pudicombe SM, Davies DE. The role of MAP kinases in intracellular signal transduction in bronchial epithelium. Clin Exp Allergy 2000; 30:7-11.
44. Ridley SH, Sarsfield SJ, Lee JC et al. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 1997; 158:3165-73.
45. 2 synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-κB. J Neurochem 2000; 75:2020-8.
46. 2 release via mechanistically distinct processes. Br J Pharmacol 2000; 130:1353-61.
47. 2 biosynthesis by IL-1β is mediated by PKC and mitogen-activated protein kinases in murine astrocyte. Br J Pharmacol 2000; 131:152-9.
48. 2 by oncogene ras is mediated through the JNK and ERK pathway in rat epithelial cells. J Biol Chem 2001; 276:1226-32.
49. 2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett 1997; 420:28-32.
50. 2 release but has no effect on von Willebrand factor secretion on E-selectin. FEBS Lett 1996; 388:180-4.
51. 2 synthesis in endothelium. Am J Physiol Cell Physiol 2001; 281:C1266-76.
52. Laporte JD, Moore PE, Panettieri RA, Moeller W, Heyder J, Shore SA. Prostanoids mediate IL-1β-induced β-adrenergic hyporesponsiveness in human airway smooth muscle cells. Am J Physiol 1998; 275:L491-501.
53. Shore SA, Laporte J, Hall IP, Hardey E, Panettieri Jr RA. Effect of IL-1β on response of cultured human airway smooth muscle cells to bronchodilator agonists. Am J Respir Cell Mol Biol 1997; 16:702-12.
54. Pang L. COX-2 expression in asthmatic airways the story so far. Thorax 2001; 56:335-6.
55. Sousa AR, Pfister R, Christie PE et al. Enhanced expression of cyclooxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997; 52:940-5.
56. Redington AE, Meng QH, Springall DR et al. Increased expression of inducible nitric oxide synthetase and cyclooxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax 2001; 56:351-7.
57. Pizzichini MMM, Pizichini E, Efthimiadis A et al. Asthma and natural colds, inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998; 158:1178-84.
58. 2 and other cyclooxygenase product of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol 1984; 133:2138-44.
59. Hilkens CM, Snijders A, Snijdewint FG, Wierenga EA, Kasenberg ML. Modulation of T-cell cytokine secretion by accessory cell-derived products. Eur Respir J Suppl 1996; 22:90s-4s.